{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:24:12Z","timestamp":1794857052920,"version":"4.9.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>Urinary tract infection (UTI) is one of the more common perinatal complications, affecting approximately 8% of pregnancies (1, 2). These infections represent a spectrum, from asymptomatic bacteriuria, to symptomatic acute cystitis, to the most serious, pyelonephritis. The presence of UTIs has been associated with adverse pregnancy outcomes, including increased rates of preterm delivery and low birth weight. Screening for and treating asymptomatic bacteriuria have been shown in multiple studies to reduce the incidence of pyelonephritis in pregnancy (3\u20135). Given the frequency at which UTIs are encountered in pregnancy, the ability to recognize, diagnose, and treat them is essential for those providing care to pregnant individuals. This Clinical Consensus document was developed using an established protocol in conjunction with the authors listed.<\/jats:p>","DOI":"10.1097\/aog.0000000000005269","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T17:08:26Z","timestamp":1689872906000},"page":"435-445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":96,"title":["Urinary Tract Infections in Pregnant Individuals"],"prefix":"10.1097","volume":"142","member":"276","reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1576\/toag.10.3.156.27418","article-title":"Urinary tract infection in pregnancy","volume":"10","author":"McCormick","year":"2008","journal-title":"Obstet Gynaecol"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0891-5520(20)30151-3","article-title":"Bacteriuria in pregnancy","volume":"1","author":"Patterson","year":"1987","journal-title":"Infect Dis Clin North Am"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R4-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000490.pub4","article-title":"Antibiotics for asymptomatic bacteriuria in pregnancy","author":"Smaill","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/jama.2019.13069","article-title":"Screening for asymptomatic bacteriuria in adults: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"371","DOI":"10.17772\/gp\/1744","article-title":"Urinary tract infection in pregnant population, which empirical antimicrobial agent should be specified in each of the three trimesters?","volume":"85","author":"Unlu","year":"2014","journal-title":"Ginekol Pol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2006.02.009","article-title":"Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). NAUTICA Group","volume":"27","author":"Zhanel","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2165\/00003495-200161140-00006","article-title":"Pyelonephritis in pregnancy: treatment options for optimal outcomes","volume":"61","author":"Wing","year":"2001","journal-title":"Drugs"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"100540","DOI":"10.1016\/j.ajogmf.2021.100540","article-title":"Bad bugs: antibiotic-resistant bacteriuria in pregnancy and risk of pyelonephritis","volume":"4","author":"Denoble","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0889-8545(05)70219-9","article-title":"Urinary tract infections during pregnancy","volume":"28","author":"Gilstrap","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2165\/11538050-000000000-00000","article-title":"Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes","volume":"70","author":"Jolley","year":"2010","journal-title":"Drugs"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/AOG.0000000000004520","article-title":"ACOG methodology: clinical consensus methodology. American College of Obstetricians and Gynecologists","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1473-3099(15)00070-5","article-title":"Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial","volume":"15","author":"Kazemier","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/bmj.295.6592.270","article-title":"Is screening for bacteriuria in pregnancy worthwhile?","volume":"295","author":"Foley","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1515\/jpm-2020-0322","article-title":"Optimal timing to screen for asymptomatic bacteriuria during pregnancy: first vs second trimester","volume":"49","author":"Langermans","year":"2021","journal-title":"J Perinat Med"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000149154.96285.a0","article-title":"Acute pyelonephritis in pregnancy","volume":"105","author":"Hill","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0031-1295655","article-title":"First-trimester pyelonephritis is associated with later initiation of prenatal care: a retrospective cohort analysis","volume":"29","author":"McDonnold","year":"2012","journal-title":"Am J Perinatol"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejogrb.2020.08.004","article-title":"The prevalence of positive urine dipstick testing and urine culture in the asymptomatic pregnant woman: a cross-sectional study","volume":"253","author":"O'Leary","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/AOG.0b013e31827e8cfe","article-title":"Contamination rates of three urine-sampling methods to assess bacteriuria in pregnant women","volume":"121","author":"Schneeberger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ucl.2006.10.010","article-title":"Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy","volume":"34","author":"Macejko","year":"2007","journal-title":"Urol Clin North Am"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.AOG.0000285995.41769.83","article-title":"Perinatal and maternal outcomes in women with sickle or hemoglobin C trait","volume":"110","author":"Tita","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0020-7292(90)90649-6","article-title":"Sickle trait and its association with birthweight and urinary tract infections in pregnancy","volume":"33","author":"Baill","year":"1990","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00404-021-06058-y","article-title":"Pregnancy outcomes in women with a hemoglobinopathy trait: a multicenter, retrospective study","volume":"304","author":"Kasparek","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2017.12.013","article-title":"Asymptomatic bacteriuria and urinary tract infection in pregnant women with and without diabetes: cohort study","volume":"222","author":"Schneeberger","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R26-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000491.pub3","article-title":"Duration of treatment for asymptomatic bacteriuria during pregnancy","author":"Widmer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"106018","DOI":"10.1016\/j.ijantimicag.2020.106018","article-title":"Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ucl.2006.10.007","article-title":"Anatomic and functional changes of the lower urinary tract during pregnancy","volume":"34","author":"FitzGerald","year":"2007","journal-title":"Urol Clin North Am"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000068957","article-title":"Voiding symptoms in pregnancy: an assessment with international prostate symptom score","volume":"55","author":"Aslan","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"R31-20250423","first-page":"1153","article-title":"Urinalysis: a comprehensive review","volume":"71","author":"Simerville","year":"2005","journal-title":"Am Fam Physician"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2017.12.231","article-title":"Diagnosis and treatment of urinary tract infections across age groups","volume":"219","author":"Chu","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.54.12.911","article-title":"ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection","volume":"54","author":"Graham","year":"2001","journal-title":"J Clin Pathol"},{"key":"R34-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002256.pub2","article-title":"Treatments for symptomatic urinary tract infections during pregnancy","author":"Vazquez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur Urol"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/14787210.2020.1759420","article-title":"Antibiotic resistant profile of asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis","volume":"18","author":"Emami","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jcph.139","article-title":"Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations","volume":"53","author":"Goldberg","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ucl.2015.05.004","article-title":"Urinary tract infection and bacteriuria in pregnancy","volume":"42","author":"Glaser","year":"2015","journal-title":"Urol Clin North Am"},{"key":"R40-20250423","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ijgo.14087","article-title":"Single-dose antibiotic therapy for urinary infections during pregnancy: a systematic review and meta-analysis of randomized clinical trials","volume":"159","author":"Schulz","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"R41-20250423","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s15010-019-01342-1","article-title":"Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study","volume":"48","author":"Philipps","year":"2020","journal-title":"Infection"},{"key":"R42-20250423","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14767058.2017.1373761","article-title":"Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin","volume":"32","author":"Mannucci","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R43-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009279.pub3","article-title":"Interventions for preventing recurrent urinary tract infection during pregnancy","author":"Schneeberger","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R44-20250423","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/j.jogc.2017.08.017","article-title":"No. 250-recurrent urinary tract infection","volume":"39","author":"Epp","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R45-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001209.pub2","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R46-20250423","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bjid.2020.04.002","article-title":"Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC\/ML (Brazilian Society of Clinical Pathology\/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women","volume":"24","author":"de Rossi","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"R47-20250423","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/JU.0000000000000296","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J Urol"},{"key":"R48-20250423","doi-asserted-by":"crossref","first-page":"100558","DOI":"10.1016\/j.ajogmf.2021.100558","article-title":"Clinical findings predictive of maternal adverse outcomes with pyelonephritis","volume":"4","author":"Stephens","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R49-20250423","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2013.10.006","article-title":"Acute pyelonephritis in pregnancy: an 18-year retrospective analysis","volume":"210","author":"Wing","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R50-20250423","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2005.12.005","article-title":"Are blood cultures necessary in the management of women with complicated pyelonephritis?","volume":"53","author":"Chen","year":"2006","journal-title":"J Infect"},{"key":"R51-20250423","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.clp.2005.05.006","article-title":"Urinary tract infections in pregnancy","volume":"32","author":"Mittal","year":"2005","journal-title":"Clin Perinatol"},{"key":"R52-20250423","first-page":"249","article-title":"A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy","volume":"92","author":"Wing","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R53-20250423","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0002-9378(95)90100-0","article-title":"Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial","volume":"172","author":"Sanchez-Ramos","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R54-20250423","first-page":"30","article-title":"Pyelonephritis in pregnancy. How adequate is empirical treatment?","volume":"26","author":"Artero","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"R55-20250423","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00404-020-05903-w","article-title":"A systematic review and meta-analysis on the prevalence of Escherichia coli and extended-spectrum \u03b2-lactamase-producing Escherichia coli in pregnant women","volume":"303","author":"Moradi","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"R56-20250423","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0974-2727.86842","article-title":"Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options","volume":"3","author":"Rizvi","year":"2011","journal-title":"J Lab Physicians"},{"key":"R57-20250423","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","article-title":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli","volume":"55","author":"Melzer","year":"2007","journal-title":"J Infect"},{"key":"R58-20250423","doi-asserted-by":"crossref","first-page":"891426","DOI":"10.1155\/2008\/891426","article-title":"Ampicillin resistance and outcome differences in acute antepartum pyelonephritis","volume":"2008","author":"Greer","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R59-20250423","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/00365549109023404","article-title":"Efficacy of long-term antimicrobial prophylaxis after acute pyelonephritis in pregnancy","volume":"23","author":"Sandberg","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"R60-20250423","first-page":"895","article-title":"Pyelonephritis in pregnancy. The role of in-hospital management and nitrofurantoin suppression","volume":"32","author":"Van Dorsten","year":"1987","journal-title":"J Reprod Med"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000005779","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:01:27Z","timestamp":1745424087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005269","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}